Who makes TAS-303, [14C]TAS-303?

TAS-303, [14C]TAS-303 is developed by Taiho Pharmaceutical Co., Ltd..

What development phase is TAS-303, [14C]TAS-303 in?

TAS-303, [14C]TAS-303 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

TAS-303, [14C]TAS-303

Taiho Pharmaceutical Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	TAS-303, [14C]TAS-303
Sponsor	Taiho Pharmaceutical Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TAS-303, [14C]TAS-303 CI brief — competitive landscape report
TAS-303, [14C]TAS-303 updates RSS · CI watch RSS
Taiho Pharmaceutical Co., Ltd. portfolio CI